Clinico Pathological Patterns and Treatment Outcomes of Pediatric Germ Cell Tumors Treated at Tikur Anbessa Hospital: A 10-Year Single Tertiary Hospital Experience

dc.contributor.advisorArega,Gashaw(MD, MPH)
dc.contributor.authorGebrehiwot,Mihret
dc.date.accessioned2025-08-12T15:27:49Z
dc.date.available2025-08-12T15:27:49Z
dc.date.issued2024-04
dc.description.abstractBackground:Pediatric Germ Cell Tumors (GCTs) are rare heterogeneous neoplasms with a peak incidence in children younger than 4 years old and during adolescence. The clinical presentation and treatment outcomes of GCTs are not well-studied in developing countries. The main aim of this study was to assess the clinic-pathological patterns and treatment outcomes of Pediatric Germ Cell Tumor (GCT) patients treated at Tikur Anbessa Specialized Hospital. Methods: A retrospective, cross-sectional study was conducted at Tikur Anbessa Specialized Hospital on Pediatric Germ Cell tumor patients treated from January 1, 2014, to December 31, 2023. The collected data were analyzed using a statistical package for social sciences (SPSS) version 25. The Kaplan–Meier Survival estimate was used to assess the Overall Survival (OS) and Event-Free Survival (EFS). Results: A total of ninety-one patients were included in the study. The median age at diagnosis was 4 years with a female-to-male ratio of 2.3:1. Most patients were under five years of age; constituting 61.6% (n=56). The duration of the illness from the onset of symptoms to the oncologic treatment center ranged from 2 days to 12 months with a mean duration of four months. Sacrococcygeal swelling was the commonest presenting symptom accounting for 38.2% (n=34) followed by abdominal mass (36%). Most of the patients had extracranial GCTs constituting 93.4% (n=85). Mature teratoma was the most common histology of GCTs constituting 52.6% followed by dysgerminomas (17.1%, n=13). About 42% of patients received a combination of chemotherapy and local control measures either surgery or radiotherapy. The Kaplan-Meier survival estimates showed the first and five-year OS was 95.7% and 85%, respectively. The first and five-year EFS was 95% and 84 % respectively. Conclusion:Our study showed the mean duration of the illness from the onset of symptoms to the oncologic treatment center was 4 months. Mature teratoma was the commonest histology. The 1-year and 5- year OS probabilities were better than other studies in similar settings.
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/6343
dc.language.isoen_US
dc.publisherAddis Ababa University
dc.subjectGerm cell tumors
dc.subjectPediatric
dc.subjectHistology
dc.subjectChemotherapy
dc.subjecttreatment outcome
dc.subjectEthiopia
dc.titleClinico Pathological Patterns and Treatment Outcomes of Pediatric Germ Cell Tumors Treated at Tikur Anbessa Hospital: A 10-Year Single Tertiary Hospital Experience
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Mihret Gebrehiwot.pdf
Size:
418.83 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: